PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-206.91%
Both yoy net incomes decline, with CRON.TO at -379.11%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
72.21%
D&A growth well above CRON.TO's 19.51%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
93.68%
Well above CRON.TO's 100.00% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
173.72%
SBC growth well above CRON.TO's 3.98%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-136.79%
Negative yoy working capital usage while CRON.TO is 917.13%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
256.17%
AR growth well above CRON.TO's 13.87%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
172.12%
Inventory shrinking or stable vs. CRON.TO's 511600.00%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-226.18%
Negative yoy AP while CRON.TO is 415.20%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
1286.83%
Some yoy usage while CRON.TO is negative at -95.91%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
221.21%
Lower 'other non-cash' growth vs. CRON.TO's 3708.09%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-102.79%
Negative yoy CFO while CRON.TO is 21.68%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
70.57%
Some CapEx rise while CRON.TO is negative at -18.27%. John Neff would see competitor possibly building capacity while we hold back expansions.
94.33%
Some acquisitions while CRON.TO is negative at -107.83%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-98.10%
Negative yoy purchasing while CRON.TO stands at 100.13%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
29401.65%
We have some liquidation growth while CRON.TO is negative at -100.24%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-99.24%
We reduce yoy other investing while CRON.TO is 99.02%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
94.92%
Investing outflow well above CRON.TO's 96.21%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-134.77%
We cut debt repayment yoy while CRON.TO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.